weight loss rate on tirzepatide Our management program: 12 months of semaglutide, 7 months of Monthly GLP-1 for Weight Maintenance

Ozempic and metformin are both effective medications in the treatment of diabetes, and both are approved as first-line treatment choices

The LEADER-derived CV risk prediction model predicted CV risk in the semaglutide data satisfactorily (the AUC [95% CI] of 0.77 [0.74;0.79] indicated a fair predictive performance [32]

Hypoglycaemia (low blood sugar) is uncommon when Ozempic is used alone but becomes more likely when combined with insulin or sulphonylureas

One of the most exciting advancements in peptide therapy is Ipamorelin, a growth hormone secretagogue with the potential to significantly impact your health and well-being